Profile

Dianna Sue Howard, M.D.Wake Forest School of Medicine

Doctor Rating

No Rating Available
Why No Ratings?

Dianna Sue Howard, M.D.

Professor,

Clinical Interests

Acute Leukemias, Acute and Chronic Leukemia, Blood and Marrow Transplant, Bone Marrow and Stem Cell Transplantation, Hematologic Malignancies, Hematopoietic Stem Cell Transplantation, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-5440
Department: 336-716-4464

Insurance Accepted »

Education & Training

  • B.A., Transylvania University, 1986
  • M.D., University of Kentucky, 1991
  • Internship, Internal Medicine, U Kentucky Med Ctr, 1992
  • Residency, Internal Medicine, U Kentucky Med Ctr, 1995
  • Fellowship, Hematology And Oncology, University of Kentucky College, 1999

Board Certifications

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Internal Medicine, Hematology
  • American Board of Internal Medicine, Internal Medicine, Medical Oncology
  • American Board of Pediatrics, Pediatrics

NPI Number

  • 1730109307
Dianna Sue Howard, M.D.

Doctor Rating

No Rating Available
Why No Ratings?

Dianna Sue Howard, M.D.

Professor, Hematology & Oncology
Comprehensive Cancer Center

Research Interests

cancer/oncogenesis

Contact Information

Academic: 336-716-4464 | Department: 336-716-4464

Recent Publications

Pardee TS, Stadelman K, Isom S, Ellis LR, Berenzon D, Hurd DD, Howard DS, Harrelson R, Manuel M, Dralle S, Lyerly S, Powell BL. Activity of the mitochondrial metabolism inhibitor cpi-613 in combination with high dose Ara-C (HDAC) and mitoxantrone in high risk relapsed or refractory acute myeloid leukemia (AML) [abstract]. J Clin Oncol. 2015;33(15 Suppl):7015.

Horton TM, Perentesis JP, Gamis AS, Alonzo TA, Gerbing RB, Ballard J, Adlard K, Howard DS, Smith FO, Jenkins G, Kelder A, Schuurhuis GJ, Moscow JA. A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2014;61(10):1754-1760.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Hematology & Oncology

Clinical Interests

Acute Leukemias, Acute and Chronic Leukemia, Blood and Marrow Transplant, Bone Marrow and Stem Cell Transplantation, Hematologic Malignancies, Hematopoietic Stem Cell Transplantation, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes
Dianna Sue Howard, M.D.

Dianna Sue Howard, M.D.

Professor, Hematology & Oncology
Comprehensive Cancer Center




Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

11/2/2015

Excellent experience.

10/11/2015

Dr. Howard a Great Person

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.